should buy now, page-62

Thats why i typed that paragraph AcesHigh.its p[ut in laymans terns for the novice to understand.
I believe ATL1103 will nwipe out Somavert in one hit as you suggested and this will in turn bring Antisense a market cap initially some where in around the 100 million mark(10 cent price range).
("Then there is the title on the presentation itself which reads "ATL1103 Clinical Development Presentation")Well spotted AcesHigh this was placed in the latest presentation as they will from clinical trials move on to developement of ATL1103.
All in all a bargain priced ANTICANCER company, and in my view the opportunity to get on board in the pre developement stage.
Robstttarrrrrr